Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quanlu Pill (also known as Quanlu Wan) is a traditional Chinese medicine (TCM) formulation manufactured and marketed by Universe Pharmaceuticals. It is formulated as an oral pill (typically water-honey pills) and is indicated for the treatment and relief of common chronic health conditions in the elderly, including spleen and kidney deficiency, qi and blood deficiency, and physical weakness. The formulation is a complex mixture of multiple natural ingredients, with dried deer (Cervus) as a key component, along with other traditional herbs such as Cynomorii Herba, Codonopsis Radix, Rehmanniae Radix, Rubi Fructus, and Cistanche. It is designed to tonify the kidneys, enrich essence, and invigorate the spleen and Qi to promote physical wellness and longevity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Quanlu Pill.